Insider Selling: Phreesia, Inc. (NYSE:PHR) General Counsel Sells 1,238 Shares of Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 1,238 shares of the stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $22.86, for a total transaction of $28,300.68. Following the completion of the transaction, the general counsel now owns 135,621 shares of the company’s stock, valued at $3,100,296.06. The sale was disclosed in a document filed with the SEC, which is available through this link.

Phreesia Trading Down 4.2 %

PHR opened at $21.67 on Friday. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.78 and a quick ratio of 1.78. Phreesia, Inc. has a 12-month low of $12.05 and a 12-month high of $34.98. The company’s 50 day moving average is $24.28 and its 200 day moving average is $21.28.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.58) by $0.02. The firm had revenue of $95.00 million for the quarter, compared to analysts’ expectations of $93.52 million. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The company’s revenue for the quarter was up 24.0% compared to the same quarter last year. During the same quarter last year, the business posted ($0.72) earnings per share. As a group, equities analysts expect that Phreesia, Inc. will post -1.48 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Phreesia

Several institutional investors and hedge funds have recently modified their holdings of the stock. State of Wyoming raised its position in shares of Phreesia by 34.6% during the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock valued at $59,000 after buying an additional 493 shares during the last quarter. American International Group Inc. raised its position in shares of Phreesia by 2.3% during the fourth quarter. American International Group Inc. now owns 26,342 shares of the company’s stock valued at $610,000 after buying an additional 591 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in shares of Phreesia by 3.6% during the second quarter. The Manufacturers Life Insurance Company now owns 20,545 shares of the company’s stock valued at $637,000 after buying an additional 710 shares during the last quarter. Capital Impact Advisors LLC increased its position in Phreesia by 4.2% in the fourth quarter. Capital Impact Advisors LLC now owns 21,262 shares of the company’s stock worth $688,000 after purchasing an additional 851 shares during the last quarter. Finally, Captrust Financial Advisors increased its position in Phreesia by 154.6% in the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock worth $36,000 after purchasing an additional 866 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Analyst Upgrades and Downgrades

PHR has been the subject of a number of analyst reports. Barclays initiated coverage on shares of Phreesia in a research note on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 price objective for the company. JMP Securities raised their price objective on shares of Phreesia from $28.00 to $30.00 and gave the company a “market outperform” rating in a research note on Thursday, March 21st. DA Davidson restated a “neutral” rating and set a $32.00 price objective on shares of Phreesia in a research note on Friday, March 15th. Needham & Company LLC restated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research note on Friday, March 15th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $23.00 price objective on shares of Phreesia in a research note on Thursday, March 21st. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $31.62.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.